MedTrace Logo

Gynecologic Extramammary Paget's Disease

NCT03564483 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-01-28

No results posted yet for this study

Summary

In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.

Conditions

  • Extramammary Paget's Disease
  • Extramammary Paget Disease
  • Paget Disease, Extramammary
  • Extramammary Paget's Disease of Vulva (Diagnosis)
  • Extramammary Paget's Disease of Vagina (Diagnosis)
  • Extramammary Paget's Disease Vulva Invasive
  • Extramammary Paget's Disease of Anus (Diagnosis)
  • Extramammary Paget's Disease of Anal Canal (Diagnosis)
  • Extramammary Paget's Disease of Skin

Sponsors & Collaborators

Principal Investigators

  • Jamie N. Bakkum-Gamez, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-19
Primary Completion
2050-12-31
Completion
2050-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03564483 on ClinicalTrials.gov